Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up. [PDF]
Gavrilova T +7 more
europepmc +1 more source
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. [PDF]
Dong Y +16 more
europepmc +1 more source
Anti Rituximab antibody titer and therapeutic response in Non-Hodgkin Lymphoma Patient Receiving R-Chop Treatment [PDF]
Roethmia Yaniari +2 more
openalex
IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers. [PDF]
Yang K +11 more
europepmc +1 more source
An Autopsy Case of Bronchiolitis Obliterans Associated With Oral Lichen Planus and Non-Hodgkin Lymphoma. [PDF]
Kurashina K +7 more
europepmc +1 more source
Comprehensive investigation of cuproptosis-related genes in clinical features, biological characteristics, and immune microenvironment in B-cell Non-Hodgkin lymphoma. [PDF]
Liu C +10 more
europepmc +1 more source
Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation Study. [PDF]
Shi X, Wallach JD, Ma X, Rogne T.
europepmc +1 more source
Trends and projections of Non-Hodgkin lymphoma burden (1990-2040): a global burden of disease 2021 analysis. [PDF]
Wang S, Zhou H, Liu Y, Li Y, Nie L.
europepmc +1 more source

